A combined longitudinal MRI analysis assessing spectroscopic, brain volume and focal brain tissue changes suggests a limited effect of immunomodulatory agents on the progression of relapsing-remitting multiple sclerosis

類似資料

• Progressive brain tissue loss and reduction of N-acetylaspartate despite immunomodulatory therapy in relapsing-remitting multiple sclerosis: results of a longitudinal single-centre study analysing MR spectroscopic, brain volume and focal tissue changes
  著者:: Enzinger, C, 等
  出版事項: (2005)
• Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis.
  著者:: Giorgio, A, 等
  出版事項: (2010)
• Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
  著者:: Marisa Loitfelder, 等
  出版事項: (2014-01-01)
• Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.
  著者:: Enzinger, C, 等
  出版事項: (2004)
• Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis
  著者:: Akram Dastagir, 等
  出版事項: (2018-09-01)